merged_drug-prices-medicare.txt
<question_number>1</question_number>
<answer>Cap next year; negotiated prices in 2026</answer>
<question_number>2</question_number>
<answer>While the number of negotiated drugs is set to increase, Project 2025 advocates repealing the program under a future Republican administration</answer>
<question_number>3</question_number>
<answer>Casts a decisive legislative vote and has prioritized drug pricing reforms in her campaign</answer>
<question_number>4</question_number>
<answer>N/A</answer>
<question_number>5</question_number>
<answer>$1,716</answer>
<question_number>6</question_number>
<answer>AbbVie and Johnson & Johnson</answer>
<question_number>7</question_number>
<answer>Januvia</answer>
<question_number>8</question_number>
<answer>Approximately 92.5%</answer>
<question_number>9</question_number>
<answer>$19</answer>
<question_number>10</question_number>
<answer>N/A</answer>